You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: RE38253


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: RE38253
Title: Composition for contraception
Abstract:A combination product for oral contraception is disclosed comprising an estrogen selected from 2.0 to 6.0 mg of 17.beta.-estradiol and 0.020 mg of ethinylestradiol; and a gestagen selected from .[.0.25 to 0.30.]. .Iadd.2.5 to 3.0 .Iaddend.mg of drospirenone and .[.0.1 to 0.2.]. .Iadd.1 to 2 .Iaddend.mg of cyproterone acetate, followed by 5 or 4 pill-free or sugar pill days.
Inventor(s): Spona; Jurgen (Vienna, AT), Dusterberg; Bernd (Berlin, DE), Ludicke; Frank (Geneva, CH)
Assignee: Schering Aktiengesellschaft (Berlin, DE)
Application Number:10/080,617
Patent Claim Types:
see list of patent claims
Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

Patents are a crucial component of intellectual property law, providing inventors and companies with exclusive rights to their innovations. In the United States, the patent system is governed by the Patent Act (35 U.S. Code) and administered by the United States Patent and Trademark Office (USPTO). This article will delve into the scope and claims of U.S. patents, using the example of a reissued patent, such as U.S. Patent RE38253, to illustrate key concepts and practices.

Types of Patents

In the U.S., there are several types of patents, each protecting different aspects of an invention.

Utility Patents

Utility patents are the most common type and protect the functional aspects of an invention. They have a duration of 20 years from the date of filing but are not enforceable until the day of issuance[1][4].

Design Patents

Design patents protect the visual and ornamental characteristics of an article of manufacture. These patents are particularly relevant for inventions where the appearance is a key factor[1][4].

Plant Patents

Plant patents cover new varieties of asexually reproducing plants. This type is essential for agricultural and horticultural innovations[1][4].

Patent Application and Examination Process

To obtain a patent, an applicant must submit a patent application to the USPTO. The application undergoes a rigorous examination process to determine if the invention is patentable.

Patent Subject Matter Eligibility

The patent application must meet the criteria under Section 101 of the Patent Act, which defines what subject matter is eligible for patent protection. This includes four statutory categories: processes, machines, manufactures, and compositions of matter. The application must also pass the Alice test to ensure the invention is not an abstract idea or natural phenomenon without an inventive concept[1].

Claim Analysis

The claims section of a patent application is critical as it defines the scope of the invention. Claims must be clear, concise, and supported by the description in the patent specification. Analyzing claims involves evaluating their scope, ensuring they cover the intended technology, and identifying any gaps or opportunities in the patent landscape[3].

Patent Claims and Scope

Claim Coverage Matrix

A Claim Coverage Matrix is a tool used to categorize patents by their claims and scope concepts. This helps in understanding which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist. This matrix is particularly useful for managing large portfolios of patents[3].

Claim Charts

Claim charts are interactive tools generated by software like ClaimScape®. These charts help technical experts, engineers, and management to review patent coverage and determine if a particular scope concept is applicable to a target product or method. They also highlight future design opportunities and areas where claim coverage is lacking[3].

Patent Landscape Analysis

Tracking Patents by Claims and Scope Concepts

To effectively manage a patent portfolio, it is essential to track patents not only by their individual claims but also by the overarching scope concepts. This approach allows for a more comprehensive understanding of the patent landscape and helps in identifying potential gaps or opportunities for future innovation[3].

Technological Fields and Patent Activity

Patents can be classified into various technological fields using the World Intellectual Property Organization (WIPO) classification system. In the U.S., electrical and mechanical engineering patents make up a significant portion of the patents granted by the USPTO. This classification helps in understanding the distribution of patents across different technology areas and identifying trends in innovation[4].

Case Study: U.S. Patent RE38253

While specific details about U.S. Patent RE38253 are not provided here, we can apply the general principles discussed above to understand its scope and claims.

Reissued Patents

U.S. Patent RE38253 is a reissued patent, which means it was originally granted and then reissued with changes. Reissued patents can arise from various reasons, including the need to correct errors in the original patent or to broaden or narrow the scope of the claims.

Claim Analysis

To analyze the claims of U.S. Patent RE38253, one would need to review the patent specification and the claims section. This involves identifying the key elements of the invention, understanding the scope of each claim, and determining how these claims interact with other patents in the same technological field.

Patent Landscape

Understanding the patent landscape around U.S. Patent RE38253 involves identifying other patents that may be related or overlapping. This can be done using patent analytics tools that categorize patents by claims and scope concepts. By analyzing this landscape, one can identify potential competitors, gaps in coverage, and opportunities for further innovation.

Obviousness-Type Double Patenting (ODP)

In cases where multiple patents are related, such as in the example of Cellect, LLC, the issue of obviousness-type double patenting (ODP) can arise. ODP occurs when a patent claim is deemed to be an obvious variation of a prior patent claim. This can lead to the invalidation of claims, as seen in the Cellect, LLC case where the Board sustained the examiner’s determinations that the asserted claims were unpatentable under ODP[2].

Key Takeaways

  • Patent Types: Utility, design, and plant patents each protect different aspects of an invention.
  • Patent Application: The application must meet Section 101 criteria and pass the Alice test.
  • Claim Analysis: Claims define the scope of the invention and must be clear and supported by the patent specification.
  • Patent Landscape: Analyzing patents by claims and scope concepts helps in understanding coverage and identifying gaps.
  • Reissued Patents: These can arise from corrections or changes to the original patent.
  • ODP: Ensuring that claims are not obvious variations of prior claims is crucial to maintaining patent validity.

FAQs

What is the primary difference between a utility patent and a design patent?

A utility patent protects the functional aspects of an invention, while a design patent protects the visual and ornamental characteristics.

How long does a utility patent last in the United States?

A utility patent lasts for 20 years from the date of filing but is not enforceable until the day of issuance.

What is the purpose of a Claim Coverage Matrix?

A Claim Coverage Matrix helps in categorizing patents by their claims and scope concepts to identify gaps or opportunities in the patent landscape.

What is obviousness-type double patenting (ODP)?

ODP occurs when a patent claim is deemed to be an obvious variation of a prior patent claim, leading to potential invalidation of the claims.

How are patents classified technologically?

Patents are classified using the World Intellectual Property Organization (WIPO) classification system, which includes 35 International Patent Classification (IPC) technical fields.

Sources

  1. BitLaw: Patent Law in the United States.
  2. United States Court of Appeals for the Federal Circuit: In re Cellect, LLC.
  3. Schwegman Lundberg & Woessner: Patent Analytics.
  4. National Science Foundation: Invention: U.S. and Comparative Global Trends.
  5. U.S. House of Representatives: 35 USC 282: Presumption of validity; defenses.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent RE38253

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: RE38253

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany43 44 462Dec 22, 1993

International Family Members for US Patent RE38253

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 344038 ⤷  Subscribe
Canada 2179728 ⤷  Subscribe
China 100377713 ⤷  Subscribe
China 1142185 ⤷  Subscribe
China 1611222 ⤷  Subscribe
Czech Republic 296387 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.